Jiang Ming

Jiang Ming

Auto-generated profile, based on publicly available information

Jiang Ming

Laboratory of Advanced Materials, College of Smart Materials and Future Energy, Department of Chemistry, New Cornerstone Science Laboratory, State Key Laboratory of Molecular Engineering of Polymers, Shanghai Key Laboratory of Molecular Catalysis and Innovative Materials, Shanghai Wusong Laboratory of Materials Science Fudan University Shanghai P. R. China

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2024 in Nature Photonics
Verified
Journal Article
Closed access
PDF file
JMJiang Ming
Jiang Ming
YCYing Chen
Ying Chen
HMHan Miao
Han Miao
YFYong Fan
Yong Fan
Wang ShangfengWang Shangfeng
Wang Shangfeng
FZFan Zhang
Fan Zhang

3 January 2020 in Nanoscale
Verified
Journal Article
Closed access
PDF file
JMJiang Ming
Jiang Ming
JZJinjia Zhang
Jinjia Zhang
YSYiran Shi
Yiran Shi
WYWangheng Yang
Wangheng Yang
JLJingchao Li
Jingchao Li
NZNanfeng Zheng
Nanfeng Zheng
Palladium nanosheets (Pd NSs) have recently attracted increasing research interest in the biomedical field due to their excellent near-infrared absorption, photothermal conversion capability and biocompatibility. However, the application of Pd NSs in immunotherapy has not been reported. Here, Pd NSs were used as the carriers of immunoadjuvant CpG ODNs for not only efficient delivery of CpG but also for enhancing the immunotherapeutic effects of CpG by the Pd NS-based photothermal therapy (PTT). Pd NSs had no influence on the immune system, and the prepared Pd-CpG nanocomposites, especially Pd(5)-CpG(PS), could significantly increase the uptake of CpG by immune cells and enhance the immunostimulatory activity of CpG in vitro and in vivo. With the combination of Pd(5)-CpG(PS) mediated PTT and immunotherapy, highly efficient tumor inhibition was achieved and the survival rate of the tumor-bearing mice was greatly increased depending on Pd(5)-CpG(PS) with safe near-infrared (NIR) irradiation (808 nm laser, 0.15 W cm−2). Importantly, the combination therapy induced tumor cell death and released tumor-associated antigens, which could be effectively taken up and presented by antigen presenting cells with the assistance of CpG, leading to increased TNF-α and IL-6 production and enhanced cytotoxic T lymphocyte (CTL) activity. This work provides a new paradigm of utilizing photothermal nanomaterials for safe and highly efficient cancer photothermal combined immunotherapy.

31 March 2023 in Science Advances
Verified
Journal Article
Closed access
JHJianhang Huang
Jianhang Huang
PYPeng Yu
Peng Yu
MLMochou Liao
Mochou Liao
XDXiaoli Dong
Xiaoli Dong
JXJie Xu
Jie Xu
YXYongyao Xia
Yongyao Xia
Implantable devices on the tumor tissue as a local treatment are able to work in situ, which minimizes systemic toxicities and adverse effects. Here, we demonstrated an implantable self-charging battery that can regulate tumor microenvironment persistently by the well-designed electrode redox reaction. The battery consists of biocompatible polyimide electrode and zinc electrode, which can consume oxygen sustainably during battery discharge/self-charge cycle, thus modulating hypoxia level in tumor microenvironment. The oxygen reduction in battery leads to the formation of reactive oxygen species, showing 100% prevention on tumor formation. Sustainable consumption of oxygen causes adequate intratumoral hypoxic conditions over the course of 14 days, which is helpful for the hypoxia-activated prodrugs (HAPs) to kill tumor cells. The synergistic effect of the battery/HAPs can deliver more than 90% antitumor rate. Using redox reactions in electrochemical battery provides a potential approach for the tumor inhibition and regulation of tumor microenvironment.

4 September 2025 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
JMJiang Ming
Jiang Ming
ZXZheng Xie
Zheng Xie
JWJiaxin Wu
Jiaxin Wu
FZFan Zhang
Fan Zhang

1 October 2018 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
DSDuo Sun
Duo Sun
YHYizhuan Huang
Yizhuan Huang
XZXianhua Zhang
Xianhua Zhang
JPJian Peng
Jian Peng
JLJingchao Li
Jingchao Li
NZNanfeng Zheng
Nanfeng Zheng
In this work, a novel nanoplatform based on Pd corolla–human serum albumin–indocyanine green (PdCs–HSA–ICG) was developed for cancer photothermal/photodynamic combination therapy. Pd corollas (denoted as PdCs) with good near-infrared photothermal conversion efficiency (η ≈ 37%) were first prepared and modified with human serum albumin (HSA) and indocyanine green (ICG) to get the PdCs–HSA–ICG nanocomposite. The prepared PdCs–HSA–ICG not only improves the colloid and thermal stability of ICG, but also shows a higher temperature increase than that of PdCs and free ICG as well as a comparable singlet oxygen (1O2) generation capability to that of free ICG. Upon single 808 nm laser irradiation, the photothermal (PTT)/photodynamic (PDT) combined therapeutic efficacy of PdCs–HSA–ICG at both cellular and animal levels was superior to PdCs–HSA (PTT) or free ICG (PTT and PDT), respectively. Thus, the designed PdCs–HSA–ICG nanocomposite holds great potential as a new class of photosensitive agent for cancer phototherapy.

26 November 2018 in Chemical Science
Verified
Journal Article
Open access
PDF file
JLJingchao Li
Jingchao Li
HLHongzhi Liu
Hongzhi Liu
JMJiang Ming
Jiang Ming
DSDuo Sun
Duo Sun
XCXiaolan Chen
Xiaolan Chen
NZNanfeng Zheng
Nanfeng Zheng
On account of the fascinating surface plasmon resonance (SPR) properties, the ability of passively targeting tumors and remarkable biocompatibility, two-dimensional (2D) Pd-based nanomaterials have demonstrated wide application prospects in cancer theranostics. However, the used animal models for exploring the bioapplications and biosafety of 2D Pd-based nanomaterials were usually limited to mice. To further widen their biomedical applications and promote future clinical transformation, it is necessary to make a breakthrough in animal models. In this work, Sprague Dawley (SD) rats and New Zealand rabbits were used as the experimental animals and orthotopic liver tumors or subcutaneous tumors were induced in these animals. Taking ≈5 nm small Pd nanosheets (SPNS) and 30 nm Pd@Au nanoplates (Pd@Au) as the representative 2D Pd-based nanomaterials, we investigated their biobehaviors and biosafety in rat liver & subcutaneous tumor models and rabbit liver tumors. The results indicated that SPNS and Pd@Au could still effectively accumulate on the tumor sites of these bigger animal models by the enhanced permeability and retention (EPR) effect, and the accumulation effects were closely related to their sizes. Metabolism studies confirmed that SPNS could be excreted out of rats through urine. Moreover, based on the sufficient uptake by cancer cells and passive accumulation of SPNS and Pd@Au in subcutaneous tumors in rats, we performed photothermal therapy (PTT) in vitro and in vivo. Significant tumor growth inhibition illustrated that even though the animal model was dozens of times bigger than the mouse model, the 2D Pd-based nanomaterials satisfied the requirements of being an outstanding photothermal reagent. Finally, the hematological and histological examination results suggested that SPNS and Pd@Au had favorable biocompatibility in rats and rabbits at a given dose. We hope this work will drive the development of 2D Pd-based nanomaterials towards practical clinical applications and provide a guide for other theranostic nanoplatforms that will be applied in bigger animal tumor models in the future.